---
title: Webinar: Identifying Oncogenic miRNAs via Alternative Splicing
description: Gain insights into the role of miRNAs in disease and explore how the right bioinformatics solution can accelerate drug discovery in cancer research.
image: https://almaden.io/hubfs/David%20Corey%20Webinar%20Email%20Header%20Image.png
---

 "

[![Almaden](https://almaden.io/hubfs/AlmadenLogo_H_White.svg)](https://almaden.io/)

[CONTACT US](https://almaden.io/contact-us)

![Featured](https://almaden.io/hubfs/David%20Corey%20Webinar%20Email%20Header%20Image.png)

# Webinar: Identifying Oncogenic miRNAs via Alternative Splicing

August 31, 2023

In this webinar, David Corey, professor of pharmacology and biochemistry at UT Southwestern Medical Center, discusses his team’s work revealing a novel RNAi mechanism controlling gene expression through splicing in colon cancer models. Their work highlights miRNAs' importance in physiology and disease. The team leveraged a state-of-the-art bioinformatics platform that delivered insights in as little as two weeks and shows how democratizing bioinformatics with reproducible computation, interpretability, and user-friendliness accelerates discovery. 

[Viewers will learn how to:](https://link.genomeweb.com/click/30585847.1/aHR0cHM6Ly9ldmVudC5vbjI0LmNvbS93Y2Mvci80MDg5ODkzLzQwRkIwMEMzREIyNzc0RDkyNUY5M0U4NTQ2MUI3MEJGP3BhcnRuZXJyZWY9ZWJsYXN0Ng/63cfeb6b92f786c89f0bce46E92c7ebb3)

1. Argonaute proteins' binding in human nuclear RNA and its effects on alternative splicing in colon cancer model systems.
2. How to use RNAseq to analyze the effect of increasing cell density on gene expression and better understand human RNAi.
3. Steps to identify a therapeutic target and develop a drug discovery program that might be able to successfully target a miRNA.
4. How biologists with limited coding experience can overcome common challenges in contributing to large-scale data analysis.

 

 

 

## Speakers

![david-corey-300x300](https://almaden.io/hs-fs/hubfs/david-corey-300x300.jpg?width=150&height=150&name=david-corey-300x300.jpg)

David Corey, PhD  
Professor, Pharmacology & Biochemistry  
UT Southwestern Medical Center

 

 

David Corey is a professor at UT Southwestern Medical Center and principal investigator for the Corey Lab. He received his undergraduate training in chemistry at Harvard University and his doctorate in chemistry at the University of California at Berkeley. He did postdoctoral work at the University of California at San Francisco before joining UT Southwestern in 1992. He currently serves as the president of the Oligonucleotide Therapeutics Society and is also executive editor for Nucleic Acids Research, which is responsible for handling 250 manuscripts per year. Corey's area of interest is the modulation of gene expression by synthetic nucleic acids.

 

![mark_headshot](https://almaden.io/hs-fs/hubfs/mark_headshot.jpeg?width=150&height=150&name=mark_headshot.jpeg)

Mark Kunitomi, PhD   
Chief Scientific Officer and Co-Founder   
Almaden Genomics

 

 

Mark Kunitomi is the chief scientific officer and co-founder of Almaden Genomics. With over a decade of experience in research and development, he brings a wealth of knowledge and expertise to the company. Kunitomi received his doctorate from University of California, San Francisco. He focuses on the development of cutting-edge software and algorithms for the analysis and interpretation of bioinformatic data. He is a recognized leader in the field, with numerous publications and patents to his name. At Almaden Genomics, Kunitomi leads a team of highly skilled scientists and engineers, working to bring innovative solutions to the market and advancing the field of genomics.

[![Almaden](https://almaden.io/hubfs/AlmadenLogo_H_White.svg)](https://almaden.io/)

Almaden Genomics accelerates scientific discovery for bioinformaticians and their teams through its intuitive and user-friendly g.nome platform. This visual workspace allows anyone from the team to drag and drop toolkits from a curated library, speeding pipeline development from months to minutes.

Quick Links

- [Home](https://almaden.io)
- [Contact Us](https://almaden.io/contact-us)
- [Privacy Policy](https://almaden.io/privacy-policy)
- [Security](https://almaden.io/security)
- [Acceptable Use Policy](https://almaden.io/acceptable-use-policy)

Contact

1409 Botham Jean Blvd.  
Office 1500  
Dallas, TX 75215  
469-480-3865

 Copyright 2026 Almaden Genomics, LLC. All Rights Reserved. Almaden Genomics, LLC is a [Catalyze Partners](https://catalyze.partners/) portfolio company.

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Admin",
    "url" : "https://almaden.io/blog/author/admin"
  },
  "dateModified" : "2025-03-07T22:09:42.518Z",
  "datePublished" : "2023-08-31T19:52:47.000Z",
  "headline" : "Webinar: Identifying Oncogenic miRNAs via Alternative Splicing",
  "image" : [ "https://almaden.io/hubfs/David%20Corey%20Webinar%20Email%20Header%20Image.png" ],
  "mainEntityOfPage" : {
    "@id" : "https://almaden.io/blog/identifying-oncogenic-mirnas-via-alternative-splicing",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://almaden.io/hubfs/AlmadenLogo_V_Transparent-1.png"
    },
    "name" : "Almaden Genomics"
  }
}
```

```json
{
  "@context" : "http://schema.org/",
  "@type" : "Corporation",
  "address" : {
    "@type" : "PostalAddress",
    "addressCountry" : "United States",
    "addressLocality" : "Dallas",
    "postalCode" : " TX 75215",
    "streetAddress" : "1409 Botham Jean Blvd. Suite 1007"
  },
  "logo" : "https://almaden.io/hubfs/AlmadenLogo_H.svg",
  "name" : "Almaden Genomics",
  "sameAs" : [ "https://www.instagram.com/almadengenomics/", "https://www.linkedin.com/company/almaden-genomics/", "https://twitter.com/AlmadenGenomics", "https://www.youtube.com/@almadengenomics2424" ],
  "url" : "https://almaden.io/"
}
```